{"id":964249,"date":"2026-05-18T16:28:46","date_gmt":"2026-05-18T20:28:46","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference\/"},"modified":"2026-05-18T16:28:46","modified_gmt":"2026-05-18T20:28:46","slug":"minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference\/","title":{"rendered":"Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p>BURLINGTON, Mass., May  18, 2026  (GLOBE NEWSWIRE) &#8212; Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced that Remy Luthringer, PhD, Executive Chairman &amp; Chief Executive Officer, will participate in the 2026 Jefferies Global Healthcare Conference being held June 2-4, 2026 in New York, NY.<\/p>\n<table style=\"border-collapse: collapse;width:50%;border-collapse:collapse\">\n<tr>\n<td colspan=\"2\">\n            <strong>2026 Jefferies Global Healthcare Conference<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:20%;width:20%;min-width:20%\">Format:<\/td>\n<td style=\"max-width:80%;width:80%;min-width:80%\">Fireside chat<\/td>\n<\/tr>\n<tr>\n<td>Day\/Time:<\/td>\n<td>Thursday, June 4 at 4:20 PM ET<\/td>\n<\/tr>\n<tr>\n<td>Webcast:<\/td>\n<td>Link\u00a0<a href=\"https:\/\/summitcast.meetmax.com\/view\/NgCqua4VVQjq9ibVWHVWca\/nCM7mAvwKsC89hnPRhXWJB?ukey=4799d6b736b4857ea632a4d804e661ba\" rel=\"nofollow\" target=\"_blank\">here<\/a><\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<\/table>\n<p>If you are interested in meeting with the Minerva team during the conference, please reach out to your Jefferies representative.<\/p>\n<p>A replay of the presentation will be available on the Company&#8217;s Investors &amp; Media <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xu-37cDClpQ3X6Z1kXXv9xyVmAhnarH9J-nSRLfRi3ivLESSnxD0nvtbbHRI8qgU8K_z2Jwrf4_Ip113CcH7Zi7mxt1lxBi4mLxZp-FCfjWyKSVba6eO-lRAdx9Uz4Wqm2fMM7DVQSddPwn1DYfYFg==\" rel=\"nofollow\" target=\"_blank\">Events and Presentations<\/a> webpage for ninety days following the event.<\/p>\n<p>\n        <strong>About Minerva Neurosciences<\/strong>\n      <\/p>\n<p>Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing product candidates to treat CNS diseases. Minerva\u2019s goal is to transform the lives of patients with improved therapeutic options, including roluperidone for negative symptoms of schizophrenia. For more information, please visit the Company\u2019s\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KW3rav9HzU9-sJ_stwVpsQbObnJElNCkYpf-n7BGNNO6w0AP_CN7obnXAihETvkSDMyGnReHRp99Txag-BCwbsRHUnZZnuMAp6dBUgq3528=\" rel=\"nofollow\" target=\"_blank\">website<\/a>.<\/p>\n<p>\n        <strong>Contacts:<\/strong><br \/>\n        <br \/>\n        <strong>Frederick Ahlholm<\/strong><br \/>\n        <br \/>Chief Financial Officer<br \/>Minerva Neurosciences, Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dZp4TN8k7Z4Kmj3Vc4oF2XioUtDDEZayp5HsipE2BSopg6BjQrBrbF2cB74zvXkNmb3gCLpFG2mjNdwErp_6i1Vv25HZm7cldkSD_X3jsWr_fPW6km_7H7KpszfWOtpv_eYXTiqcb-jmSY9EGjIpHA==\" rel=\"nofollow\" target=\"_blank\">FAhlholm@minervaneurosciences.com<\/a><\/p>\n<p>\n        <strong>Corey Davis, Ph.D.<\/strong><br \/>\n        <br \/>LifeSci Advisors, LLC<br \/>212-915-2577<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xngvpnEWrwwI4qvpwy958ZDYzqm03A9YO298t3fgSsVp4AqavPXJGjW1Ze0Ay3VKseIgtVJfPdxKfuQxmdKVXkTMAzPceeZyyEjLcSHBUWZ4iBfbRMJTZF9nc7SpUAnU\" rel=\"nofollow\" target=\"_blank\">cdavis@lifesciadvisors.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMjI5OCM3NjA5MTE5IzIwMDcyNDU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YjhhNzU1ZDctYjQzNi00MjBmLTk0YzAtMmJhYTRhYjA1YjUxLTEwMTg4MTgtMjAyNi0wNS0xOC1lbg==\/tiny\/Minerva-Neurosciences-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BURLINGTON, Mass., May 18, 2026 (GLOBE NEWSWIRE) &#8212; Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced that Remy Luthringer, PhD, Executive Chairman &amp; Chief Executive Officer, will participate in the 2026 Jefferies Global Healthcare Conference being held June 2-4, 2026 in New York, NY. 2026 Jefferies Global Healthcare Conference Format: Fireside chat Day\/Time: Thursday, June 4 at 4:20 PM ET Webcast: Link\u00a0here \u00a0 \u00a0 If you are interested in meeting with the Minerva team during the conference, please reach out to your Jefferies representative. A replay of the presentation will be available on the Company&#8217;s Investors &amp; Media Events and Presentations webpage for ninety days &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-964249","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BURLINGTON, Mass., May 18, 2026 (GLOBE NEWSWIRE) &#8212; Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced that Remy Luthringer, PhD, Executive Chairman &amp; Chief Executive Officer, will participate in the 2026 Jefferies Global Healthcare Conference being held June 2-4, 2026 in New York, NY. 2026 Jefferies Global Healthcare Conference Format: Fireside chat Day\/Time: Thursday, June 4 at 4:20 PM ET Webcast: Link\u00a0here \u00a0 \u00a0 If you are interested in meeting with the Minerva team during the conference, please reach out to your Jefferies representative. A replay of the presentation will be available on the Company&#8217;s Investors &amp; Media Events and Presentations webpage for ninety days &hellip; Continue reading &quot;Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-18T20:28:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMjI5OCM3NjA5MTE5IzIwMDcyNDU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare Conference\",\"datePublished\":\"2026-05-18T20:28:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference\\\/\"},\"wordCount\":199,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyMjI5OCM3NjA5MTE5IzIwMDcyNDU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference\\\/\",\"name\":\"Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyMjI5OCM3NjA5MTE5IzIwMDcyNDU=\",\"datePublished\":\"2026-05-18T20:28:46+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyMjI5OCM3NjA5MTE5IzIwMDcyNDU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyMjI5OCM3NjA5MTE5IzIwMDcyNDU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare Conference - Market Newsdesk","og_description":"BURLINGTON, Mass., May 18, 2026 (GLOBE NEWSWIRE) &#8212; Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced that Remy Luthringer, PhD, Executive Chairman &amp; Chief Executive Officer, will participate in the 2026 Jefferies Global Healthcare Conference being held June 2-4, 2026 in New York, NY. 2026 Jefferies Global Healthcare Conference Format: Fireside chat Day\/Time: Thursday, June 4 at 4:20 PM ET Webcast: Link\u00a0here \u00a0 \u00a0 If you are interested in meeting with the Minerva team during the conference, please reach out to your Jefferies representative. A replay of the presentation will be available on the Company&#8217;s Investors &amp; Media Events and Presentations webpage for ninety days &hellip; Continue reading \"Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-18T20:28:46+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMjI5OCM3NjA5MTE5IzIwMDcyNDU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare Conference","datePublished":"2026-05-18T20:28:46+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference\/"},"wordCount":199,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMjI5OCM3NjA5MTE5IzIwMDcyNDU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference\/","name":"Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMjI5OCM3NjA5MTE5IzIwMDcyNDU=","datePublished":"2026-05-18T20:28:46+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMjI5OCM3NjA5MTE5IzIwMDcyNDU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMjI5OCM3NjA5MTE5IzIwMDcyNDU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/964249","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=964249"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/964249\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=964249"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=964249"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=964249"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}